Their expression levels in EVs of HCC patients were significantly higher than those of chronic hepatitis/cirrhosis or healthy controls, presenting a potent diagnostic ability, and even better than AFP in diagnosing early-stage HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.